BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    Impression Healthcare ASX IHL AXIM gingivitis periodontitis gum disease cannabidiol CBD cannabis mouthwash toothpaste

    Impression Healthcare registers clinical trial for CBD-based mouthwash and toothpaste

    Althea Group ASX AGH MMJ first UK prescription Australian manufacturing facility

    Althea continues global growth spurt with first UK prescription and green light for Australian manufacturing facility

    Botanix Pharmaceuticals CBD cannabidiol destroys skin superbug infections BTX 1801

    Botanix’s CBD-based product destroys superbug skin infections in another ‘world first’

    OBJ ASX Little Green Pharma develop medicinal cannabis patches

    OBJ inks ‘landmark’ deal to develop medicinal cannabis patches

    Orthocell ASX OCC CelGro bone regeneration device dental implant treatment timeframes cut costs

    Orthocell’s CelGro bone regeneration device accelerates dental implant treatment timeframes, cuts costs

    Botanix Pharmaceuticals ASX BOT clinical study cannabinoid CBD anti-inflammatory immunomodulation effects skin disease plaque psoriasis

    Botanix study finds CBD has anti-inflammatory and immune modulating effects on skin disease

    Canndeo THC Global ASX manufacture medicinal cannabis extracts licence

    THC’s Canndeo gets green light to manufacture medicinal cannabis extracts

    Immuron ASX IMC US Department of Defense Travelan Shigellosis challenge study Shigella

    Immuron reports positive results from Travelan testing, develops anti-dysentery vaccine products

    Creso Pharma ASX CPH PharmaCielo cannabis acquisition Colombia

    PharmaCielo to acquire Creso Pharma for $122m

    Bod Australia ASX BDA PTSD cannabis CAC MediCabilis

    Bod Australia’s cannabis oil to be used in landmark PTSD trial

    Paradigm Biopharmaceuticals ASX PAR Ross River virus phase 2A clinical trial success

    Paradigm Biopharmaceuticals’ iPPS reduces Ross River virus joint pain

    Impression Healthcare ASX IHL AXIM cannabis CBD periodontitis toothpaste mouthwash clinical trial

    Impression Healthcare signs first binding agreement with AXIM Biotechnologies, clinical trial imminent

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2019 Small Caps. All rights reserved.